APG-115 (alrizomadlin)
NCT03781986
University of Michigan · Phase 1/2 · Active, not recruiting · Enrollment 41
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
APG-115 (alrizomadlin)
University of Michigan · Phase 1/2 · Active, not recruiting · Enrollment 41
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.